4-Pregnen-20β-ol-3-one
CAS: 145-15-3
Ref. 3D-FP65736
1mg | Ausgelaufen | ||
2mg | Ausgelaufen | ||
5mg | Ausgelaufen | ||
10mg | Ausgelaufen | ||
25mg | Ausgelaufen |
Produktinformation
- Standard for chromatography
- (20R)-20-Hydroxypregn-4-en-3-one
- 20-beta-Dihydroprogesterone
- 20-beta-Hydroxydihydroprogesterone
- 20-beta-Hydroxypregn-4-en-3-one
- 20-beta-Hydroxyprogesterone
- 20-beta-Progerol
- 20beta-Hydroxy-pregn-4-en-3-one
- 20β-Dihydroprogesterone
- 20β-Hydroxy-Δ<sup>4</sup>-pregnen-3-one
- Mehr Synonyme anzeigen
- 20β-Hydroxypregn-4-en-3-one
- 20β-Hydroxyprogesterone
- 20β-Progerol
- 4-Pregnen-2-beta-ol-3-one
- 4-Pregnene-20β-ol-3-one
- Pregn-4-en-20β-ol-3-one
- Pregn-4-en-3-one, 20-beta-hydroxy-
- Pregn-4-en-3-one, 20-hydroxy-, (20-R)- (9CI)
- Pregn-4-en-3-one, 20-hydroxy-, (20R)-
- Pregn-4-en-3-one, 20β-hydroxy-
- Pregn-4-ene-20β-hydroxy-3-one
- Progesterol-20-beta
- Progesterol-20β
- Δ4-Pregnene-20β-ol-3-one
- Δ<sup>4</sup>-Pregnen-20β-ol-3-one
- 20β-Hydroxy-Δ4-pregnen-3-one
4-Pregnen-20beta-ol-3-one is a synthetic progestin that has been shown to have both contraceptive and noncontraceptive activities. It is used primarily to treat female infertility, endometriosis, and amenorrhea. The drug also has a number of other effects on the body, including anti-inflammatory and anti-angiogenic properties. 4-Pregnen-20beta-ol-3-one binds to the human liver receptor, which is responsible for its metabolism. The drug also has some activity in the endometrium of pregnant women and in the ovary cells of postmenopausal women. It increases epidermal growth factor production in skin cells and may be involved in lipid metabolism. 4-Pregnen-20beta-ol-3-one also stimulates lactogenic hormone production in women.